Flexion Can Double Now That FDA Has Approved Zilretta

Flexion jumped 10% as it's first drug, Zilretta, was approved by the FDA. As the opioid epidemic worsens, doctors are looking for non-addictive drugs like Zilretta for patients in pain. Todd Hagopian thinks the stock can double from here.

from Forbes Real Time https://www.forbes.com/sites/kenkam/2017/10/09/flexion-can-double-now-that-fda-has-approved-zilretta/
via IFTTT